Drug intelligence / Profile preview

curodont repair

Development stage: Phase 1
Lead developer: vVARDIS
Modality: Peptides
Administration: Topical

Overview

Curodont Repair is a biomimetic dental treatment system designed for the non-invasive management of early carious lesions through Guided Enamel Regeneration. It contains a P11-4 peptide technology that diffuses into carious lesions within 5 minutes, forming a biomatrix that attracts calcium and phosphate ions from saliva. This leads to the formation of new hydroxyapatite crystals around the biomatrix, resulting in enamel regeneration and arresting caries progression. The product is specifically intended for dental professionals to treat "watch areas" - early, non-cavitated carious lesions that appear as white spots with rough but intact surfaces.

Brand names: Curodont Repair
Other names: self-assembling peptide P11-4oligopeptide P11-4

Beyond the preview

Go deeper on curodont repair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on curodont repair.

Explore the full profile